Search Results 491-500 of 24267 for Ovary

  1. Scott H. Kaufmann, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Ovarian cancer · Interests. Biology and therapy of ovarian cancer and acute leukemia. Mayo Clinic locations. Rochester, Minnesota. Driving directions ...

  2. Asma J. Chattha, M.B.B.S. - Doctors and Medical Staff - Mayo Clinic

    Polycystic ovary syndrome in adolescents · Fertility preservation in children facing gonadotoxic therapy ...

  3. Medical Research & Education - Mayo Clinic News Network

    Women's Wellness: Ovary removal and kidney disease connection featured image. Featured News. Women's Wellness: Ovary removal and kidney disease connection.

  4. Mayo Clinic SCORE on Sex Differences - Career Enhancement Core

    Ovary Removal and Aging · Ovary Removal and Dementia · Murine Model of Ovary Removal. Cores Cores. Leadership Administrative Core · Career Enhancement Core ...

  5. A Phase Ib Study Of Cobimetinib Administered In Combination With Niraparib, With or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian Cancer - Mayo Clinic

    A Phase Ib Study Of Cobimetinib Administered In Combination With Niraparib, With or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian ...

  6. Housecall: Low-carb diet benefits and risks - Mayo Clinic News Network

    Is ovary removal a risk factor for dementia? More research is needed, but removing the ovaries (oophorectomy) lowers the level of estrogen, a hormone that ...

  7. Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA) - Mayo Clinic

    Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer.

  8. Bevacizumab (intravenous route) - Side effects & uses - Mayo Clinic

    ... ovarian, fallopian tube, or primary peritoneal cancer with or without having previous surgery. Bevacizumab injection is also used together with atezolizumab ...

  9. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression - Mayo Clinic

    ... Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression. Print ... ovarian epithelial carcinoma. CA125 response is defined as ≥ 50% decrease ...

  10. Adrian Vella, M.D. - Doctors and Medical Staff - Mayo Clinic

    Polycystic ovary syndrome · Interests. Polycystic ovarian syndrome; Diabetes and genetic disorders of metabolism; Pituitary and adrenal disorders. Mayo Clinic ...